CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Sell
26
IMYSF Quote, Financials, Valuation and Earnings
Last price:
$33.18
Seasonality move
:
-11.13%
Day range:
$33.18 - $33.18
52-week range:
$27.57 - $35.92
Dividend yield:
4.42%
P/E ratio:
54.70x
P/S ratio:
0.72x
P/B ratio:
0.82x
Volume:
--
Avg. volume:
8
1-year change:
6.85%
Market cap:
$2.8B
Revenue:
$3.9B
EPS (TTM):
-$1.29
Earnings Data
Next earnings date for IMYSF
Jul 29
2025
Most recent earnings per share
$0.61
Beat by $0.61
(Feb 21/2025)
Consensus Estimate
--
(Feb 21/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IMYSF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | -- | $886.8M | $0.61 | -- | -- |
| 10/30/2024 | Q3 | -- | $940.3M | -$3.71 | -- | -- |
| 07/30/2024 | Q2 | -- | $1.1B | $0.93 | -- | -- |
| 03/31/2024 | Q1 | -- | $1B | $0.89 | -- | -- |
| 02/21/2024 | Q4 | -- | $963.2M | -$1.69 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | $0.49 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | $0.57 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | $1.29 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | $0.54 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | $1.50 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | $0.97 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $0.33 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $1.03 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | $1.00 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $1.01 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.95 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $0.54 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | $0.16 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.57 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.54 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.91 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | $0.41 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | $0.96 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $4.57 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $1.17 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $1.81 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $1.14 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $1.49 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $1.32 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | $1.30 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $1.05 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.26 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.86 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $1.22 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $1.01 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$2.65 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | $1.08 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $1.08 | -- | -- |
Imerys Earnings Questions
-
How Much did Imerys Generate in Revenue Last Quarter?
Imerys reported $886.8M worth of top line sales in its most recent quarter.
-
Did Imerys Beat Earnings Last Quarter?
Imerys announced earnings per share of $0.61 which represents a beat of analyst forecast a -- per share.
-
Is Imerys Profitable?
Imerys reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Imerys EPS Next Year?
Imerys's earnings are forecast to grow from -$1.21 per share to -- per share next year representing an increase of --.
-
When is Imerys's Earnings Date?
Imerys's next earnings date is July 29, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
